Application of proteome profiling in the clinical diagnosis of breast cancer
The Applied Biology & Chemistry Journal · 2021
DOI: 10.52679/tabcj.2021.0006 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Applied Biology & Chemistry Journal, 2021. Verfasst von Priyanti Chakraborty und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
The early diagnosis, prognosis, and anticipation of breast cancer are crucial for proper treatment and patient survival. This disease imposes quite a severe health care encumbrance on women globally. Breast cancer classification has emphasized several global efforts, and analysis of the subtypes of the molecular basis of breast cancer has aimed to associate them with clinical outcomes and improve the current diagnostic routine. Since the last two decades, proteomics-based methods for studying breast cancer's natural history and treatment are gaining traction. In this review, some of the proteome profiling studies of tissues, plasma, serum and saliva conducted mainly by mass spectrometry-based approaches – including MALDI-TOF and SELDI-TOF are discussed. This review also emphasized tissue microarray studies and their role in identifying clinical tissues and markers in breast cancer.
Zitieren
APA
Chakraborty, P., & Samanta, A. (2021). Application of proteome profiling in the clinical diagnosis of breast cancer. The Applied Biology & Chemistry Journal. https://doi.org/10.52679/tabcj.2021.0006
Vancouver
Chakraborty P, Samanta A. Application of proteome profiling in the clinical diagnosis of breast cancer. The Applied Biology & Chemistry Journal. 2021. doi:10.52679/tabcj.2021.0006
BibTeX
@article{Chakraborty2021,
author = {Chakraborty, Priyanti and Samanta, Ankita},
title = {Application of proteome profiling in the clinical diagnosis of breast cancer},
journal = {The Applied Biology & Chemistry Journal},
year = {2021},
doi = {10.52679/tabcj.2021.0006}
}
EUVIMED